NCT01362010View on ClinicalTrials.gov

Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2013

Conditions

Acne Vulgaris

Interventions

DRUG

Topical Minocycline Foam FXFM244

Topically applied once a day.

Trial Locations (3)

Unknown

Lev Yasmin clinic, Netanya

Sourasky medical center, Tel Aviv

Tel-Nordau Clalit health services, Tel Aviv

All Listed Sponsors

lead

Vyne Therapeutics Inc.

INDUSTRY

NCT01362010 - Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients | Biotech Hunter | Biotech Hunter